NYSENVO
Obat penurun berat badan ‘ajaib’ Ozempic akan memasuki negosiasi harga AS dalam waktu satu tahun, kata CEO Novo Nordisk menjelang sidang Senat – Novo Nordisk (NYSE:NVO) – Beragampengetahuan
Novo Nordisk‘S NVO CEO Lars Frørgaard Jørgensenmengungkapkan bahwa obat diabetes mereka yang sering dipuji sebagai obat penurun berat badan “ajaib”, Ozempic, akan segera memenuhi syarat untuk negosiasi harga pemerintah AS, mungkin dalam tahun depan. Apa yang telah terjadi: Jorgensen dijadwalkan memberikan kesaksian di hadapan komite Senat pada hari Selasa untuk membahas harga Ozempic dan obat […]
What’s Going On With Ozempic-Maker Novo Nordisk Stock? – Novo Nordisk (NYSE:NVO) – Beragampengetahuan
Novo Nordisk A/S NVO shares are moving Monday and the Ozempic-maker’s stock has gained more than 40% year-to-date. Here’s a look at what’s going on: What To Know: A study published in The Journal of the American Medical Association Monday stated that when study participants with obesity stopped using Eli Lily’s obesity-drug, tirzepatide, they regained […]
Ozempic Ingredient Gives Novo Nordisk’s Kidney Trial A Positive Result: What It Means For Health Care – Novo Nordisk (NYSE:NVO) – Beragampengetahuan
Novo Nordisk A/S NVO shares got a boost this week after the drugmaker halted trials testing potential treatment for kidney failure on early signs of efficacy. The study has implications for other drugmakers including Eli Lilly And Co LLY and DaVita Inc DVA. What To Know: The Independent Data Monitoring Committee recommended Novo Nordisk cut its kidney outcomes trial FLOW short after interim analysis showed the […]